跳至主要内容
临床试验/JPRN-jRCT1031180196
JPRN-jRCT1031180196招募中4 期

Optimal tapering regimens of glucocorticoid for severe systemic lupus erythematosus: multi-center randomized open label trial

Tamura Naoto0 个研究点目标入组 100 人开始时间: 2019年3月6日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Men and women aged over 20 years, able and willing to give written informed consent, fulfilled 1997 ACR classification criteria for SLE or SLICC criteria for SLE classification, have received 0.5 mg/kg/day or more and over 45mg/day of oral prednisolone or equivalent doses of corticosteroids with or without any immunosuppressant.

排除标准

  • Unable to give informed consent, have uncontrollable complications, being pregnant or a nursing woman, Men and women with plan of pregnancy within 52 weeks

研究者

发起方
Tamura Naoto

相似试验

已完成
不适用
Optimal regimens of glucocorticoids tapering for remission induction therapy in patients with severe systemic lupus erythematosus : multi-center randomized open label trialsystemic lupus erythematosus
JPRN-UMIN000035865Juntendo University44
已完成
不适用
To study the effects of 2 standard treatment-timing strategies for glucocorticoïd dosage on androgen concentration in CAH childreCongenital adrenal hyperplasia (AGS)
NL-OMON25245Radboudumc, Department of pediatric endocrinology50
已完成
不适用
Optimizing timing of glucocorticoid treatment in children with congenital adrenal hyperplasiaCAH
NL-OMON48168Radboud Universitair Medisch Centrum50
进行中(未招募)
不适用
A clinical trial to study the effect of stopping medicine in Systemic Lupus Erythematosus patients with well controlled disease
CTRI/2020/07/026712JIPMER
进行中(未招募)
1 期
Avoiding over and undertreatment by optimizing of the timing ofglucocorticoïd treatment in children with cnogenital adrenal hyperplasiaCongenital adrenal hyperplasia (CAH) is a disorder of adrenal steroidsynthesis leading to cortisol deficiency and an increase in androgenproduction.Treatment in children consists of hydrocortisone substitutionthereby also restoring the negative feedback on the pituitary gland andconsequently normalize androgen production. There is still no evidenceabout the best timing of hydrocortisone use: The highest dosage ofhydrocortisone in the morning or the highest dosage at night
EUCTR2018-004802-24-NLRadboud University Nijmegen Medical Centre50